| Pharmaceutical active ingredients: |
| Insulin Isophane Injection Porcine, monocomponent |
| Available forms, composition and doses of Monolin NPH: |
| N / A |
| Monolin NPH medical category: |
| Human:Insulin preparations |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A10AB03 - Insulin (Pork)A10AC03 - Insulin (Pork)A10AD03 - Insulin (Pork)A10AE03 - Insulin (Pork) |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Novo Nordisk |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Mixtard Human 30 | Insulin Isophane Human Injection; Insulin Neutral Injection Human | Novo Nordisk |
| Mixtard Human 30 / 70 | Insulin Isophane Human Injection; Insulin Neutral Injection Human | Novo Nordisk; Abbott; Bayer Schering Pharma |
| Mixtard Human 50 | Insulin Isophane Human Injection; Insulin Neutral Injection Human | Novo Nordisk; Abbott |
| Mixtard Human 70 / 30 | Insulin Isophane Human Injection; Insulin Neutral Injection Human | Novo Nordisk; Abbott; Bayer Schering Pharma |
| Mixtard-X Humanum | Insulin Isophane Suspension Human, emp; Insulin Neutral Injection Human, emp | Novo Nordisk |
| Monolin Regular | Insulin Neutral Injection Porcine monocomponent | Novo Nordisk |
| Monotard | Insulin Zinc Suspension Human recombinant | Novo Nordisk |
| Monotard HM | Insulin Zinc Suspension Human monocomponent amorphous; Insulin Zinc Suspension Human monocomponent crystalline | Novo Nordisk; JDH Pharmaceutical |
| Monotard MC | Insulin Zinc Suspension Porcine monocomponent amorphous; Insulin Zinc Suspension Porcine monocomponent crystalline | Novo Nordisk; Humanpharma Gyogyszergyarto |
| Nanormon | Somatropin | Novo Nordisk |